Home » Drug Information » Recently Approved Drugs » 1997
Medical Areas: Pediatrics/Neonatology | Pulmonary/Respiratory Diseases
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: GlaxoWellcome
Approval Status: Approved November 1997
Treatment Area: asthma
Flovent Rotadisk, a fluticasone inhalation powder, has been
approved for the maintenance treatment of asthma in patients four
and older. The corticosteroid is dosed twice daily and is available
in strengths of 50 mcg and 100 mcg for children and adults and in a
250 mcg for adults.
